Artificial neural networks allow the use of simultaneous measurements of Alzheimer Disease markers for early detection of the disease

Journal of Translational Medicine

Volumn 3, Issue , 2005, Pages

  Di Luca, Monica ^a   Grossi, Enzo ^b   Borroni, Barbara ^c   Zimmermann, Martina ^a   Marcello, Elena ^a   Colciaghi, Francesca ^a   Gardoni, Fabrizio ^a   Intraligi, Marco ^d   Padovani, Alessandro ^c   Buscema, Massimo ^d  

^a UNIVERSITY OF MILAN   (Italy)

^b Medical Department   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d Centro Ricerche Semeion   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ARTIFICIAL NEURAL NETWORK; BIOCHEMISTRY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISCRIMINANT ANALYSIS; DISEASE MARKER; EARLY DIAGNOSIS; FEMALE; HUMAN; LEARNING; LINEAR SYSTEM; MALE; MEASUREMENT; NONBIOLOGICAL MODEL; PERFORMANCE; POSITIVE FEEDBACK; STATISTICAL ANALYSIS;

EID: 27344457307     PISSN: 14795876     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-3-30     Document Type: Article

References (17)

1. Ritchie K, Lovestone S: The dementias. Lancet 2002, 360(9347):1759-66.
2. Nestor PJ, Scheltens P, Hodges JR: Advances in the early detection of Alzheimer's disease. Nat Med 2004, 10:S34-41.
3. No authors listed: Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group. Neurobiol Aging 1998, 19(2):109-16.
4. Di Luca M, Pastorino L, Bianchetti A, Perez J, Vignolo LA, Lenzi GL, et al: Differential level of platelet amyloid beta precursor protein isoforms: an early marker for Alzheimer disease. Arch Neurol 1998, 55(9):1195-200.
5. Baskin F, Rosenberg RN, Iyer L, Hynan I, Cullum CM: Platelet APP isoform ratios correlate with declining cognition in AD. Neurology 2000, 54(10):1907-9.
6. Padovani A, Pastorino L, Borroni B, Colciaghi F, Rozzini L, Monastero R, et al: Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD. Neurology 2001, 57(12):2243-8.
7. Colciaghi F, Borroni B, Pastorino L, Marcello E, Zimmermann M, Cattabeni F, et al: [alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients. Mol Med 2002, 8(2):67-74.
8. Colciaghi F, Marcello E, Borroni B, Zimmermann M, Caltagirone C, Cattabeni F, et al.: Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease. Neurology 2004, 62(3):498-501.
9. Lisboa PJ: A review of evidence of health benefit from artificial neural networks in medical intervention. Neural Netw 2002, 15(1):11-39.
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34(7):939-44.
11. Rumelhart DE, McClelland JL, PDP Group (eds): Parallel Distributed Processing. In vol. 1: Foundation, Vol. 2: Psychological and Biological Models Cambridge, MA: The MIT Press; 1986.
12. Buscema M, Breda M, Terzi S: Sine Net: In Semeion Technical Paper n. 21, Roma 2002.
13. Buscema M: BackPropagation Neural Networks: In Buscema & Semeion Group, Reti Neurali Artificiali e Sistemi Sociali Complessi, Teoria e Modelli. Milano: F. Angeli 1999, 1:189-222.
14. Dietterich TG: Approximate statistical tests for comparing supervised classification learning algorithms. Volume 10. Neural Computations MIT Press; 1998:1825-1923.
15. Okamura N, Arai H, Maruyama M, Higuchi M, Matsui T, Tanji H, et al.: Combined Analysis of CSF Tau Levels and [(123)I]lodoamphetamine SPECT in Mild Cognitive Impairment. Implications for a Novel Predictor of Alzheimer's Disease. Am J Psychiatry 2002, 159(3):474-6.
16. Curtis D, North BV, Sham PC: Use of an artificial neural network to detect association between a disease and multiple marker genotypes. Ann Hum Genet 2001, 65:95-107.
17. North BV, Curtis D, Cassell PG, Hitman GA, Sham PC: Assessing optimal neural network architecture for identifying disease-associated multi-marker genotypes using a permutation test, and application to calpain 10 polymorphisms associated with diabetes. Ann Hum Genet 2003, 67:348-56.